Solventum Corp (SOLV) concluded trading on Thursday at a closing price of $78.5, with 0.47 million shares of worth about $37.23 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 18.85% during that period and on July 03, 2025 the price saw a gain of about 0.32%. Currently the company’s common shares owned by public are about 173.01M shares, out of which, 138.41M shares are available for trading.
Stock saw a price change of 5.19% in past 5 days and over the past one month there was a price change of 5.71%. Year-to-date (YTD), SOLV shares are showing a performance of 52.58% which increased to 18.83% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $47.16 but also hit the highest price of $85.92 during that period. The average intraday trading volume for Solventum Corp shares is 1.12 million. The stock is currently trading 4.64% above its 20-day simple moving average (SMA20), while that difference is up 8.64% for SMA50 and it goes to 9.43% higher than SMA200.
Solventum Corp (NYSE: SOLV) currently have 173.01M outstanding shares and institutions hold larger chunk of about 67.77% of that.
The stock has a current market capitalization of $13.58B and its 3Y-monthly beta is at 0.68. PE ratio of stock for trailing 12 months is 36.17, while it has posted earnings per share of $2.17 in the same period. Its PEG reads 97.76 and has Quick Ratio of 0.85 while making debt-to-equity ratio of 2.53. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SOLV, volatility over the week remained 1.94% while standing at 1.93% over the month.
Stock’s fiscal year EPS is expected to drop by -16.85% while it is estimated to increase by 6.77% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Argus on July 01, 2025 offering a Buy rating for the stock and assigned a target price of $90 to it. On May 19, 2025, Piper Sandler Upgrade their recommendations, while on December 04, 2024, Mizuho Initiated their ratings for the stock with a price target of $70. Stock get a Buy rating from Stifel on October 08, 2024.
